文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

分化型甲状腺癌全切术后首次放射性碘治疗前后的动态免疫功能变化

Dynamic Immune Function Changes Before and After the First Radioactive Iodine Therapy After Total Resection of Differentiated Thyroid Carcinoma.

作者信息

Shi Zhi-Yong, Zhang Sheng-Xiao, Fan Di, Li Cai-Hong, Cheng Zhe-Hao, Xue Yan, Wu Li-Xiang, Lu Ke-Yi, Yang Su-Yun, Cheng Yan, Wu Zhi-Fang, Gao Chong, Li Xiao-Feng, Liu Hai-Yan, Li Si-Jin

机构信息

Department of Nuclear Medicine, First Hospital of Shanxi Medical University, Taiyuan, China.

Collaborative Innovation Center for Molecular Imaging of Precision Medicine, First Hospital of Shanxi Medical University, Taiyuan, China.

出版信息

Front Immunol. 2022 Jun 30;13:901263. doi: 10.3389/fimmu.2022.901263. eCollection 2022.


DOI:10.3389/fimmu.2022.901263
PMID:35844520
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9280633/
Abstract

The effects of total thyroidectomy or radioactive iodine therapy on immune activation and suppression of the tumor microenvironment remain unknown. We aimed to investigate the effects of these treatments on the immune function in patients with differentiated thyroid carcinoma (DTC). Our cohort included 45 patients with DTC treated with total thyroidectomy and radioactive iodine therapy (RAIT). Immune function tests were performed by flow cytometry at 0, 30, and 90 days post-RAIT. Both the percentage and absolute number of circulating regulatory T cells were significantly lower in the postoperative DTC compared to the healthy controls. Notably, the absolute number of multiple lymphocyte subgroups significantly decreased at 30 days post-RAIT compared to those pre-RAIT. The absolute counts of these lymphocytes were recovered at 90 days post-RAIT, but not at pre-RAIT levels. Additionally, the Th17 cell percentage before RAIT was positively correlated with thyroglobulin (Tg) levels after RAIT. The tumor burden might contribute to increased levels of circulating Tregs. In conclusion, RAIT caused transient radiation damage in patients with DTC and the percentage of Th17 cells before RAIT could be a significant predictor of poor prognosis in patients with DTC.

摘要

全甲状腺切除术或放射性碘治疗对肿瘤微环境免疫激活和抑制的影响尚不清楚。我们旨在研究这些治疗对分化型甲状腺癌(DTC)患者免疫功能的影响。我们的队列包括45例接受全甲状腺切除术和放射性碘治疗(RAIT)的DTC患者。在RAIT后0、30和90天通过流式细胞术进行免疫功能测试。与健康对照相比,术后DTC患者循环调节性T细胞的百分比和绝对数量均显著降低。值得注意的是,与RAIT前相比,RAIT后30天多个淋巴细胞亚群的绝对数量显著减少。这些淋巴细胞的绝对计数在RAIT后90天恢复,但未恢复到RAIT前水平。此外,RAIT前Th17细胞百分比与RAIT后甲状腺球蛋白(Tg)水平呈正相关。肿瘤负荷可能导致循环Tregs水平升高。总之,RAIT对DTC患者造成了短暂的辐射损伤,RAIT前Th17细胞百分比可能是DTC患者预后不良的重要预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e9/9280633/d2cebef69f7c/fimmu-13-901263-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e9/9280633/4c09a079e60b/fimmu-13-901263-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e9/9280633/2c4aa56cf320/fimmu-13-901263-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e9/9280633/70a6b432964a/fimmu-13-901263-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e9/9280633/d2cebef69f7c/fimmu-13-901263-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e9/9280633/4c09a079e60b/fimmu-13-901263-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e9/9280633/2c4aa56cf320/fimmu-13-901263-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e9/9280633/70a6b432964a/fimmu-13-901263-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e9/9280633/d2cebef69f7c/fimmu-13-901263-g004.jpg

相似文献

[1]
Dynamic Immune Function Changes Before and After the First Radioactive Iodine Therapy After Total Resection of Differentiated Thyroid Carcinoma.

Front Immunol. 2022-6-30

[2]
Outcomes of ATA Low-Risk Pediatric Thyroid Cancer Patients Not Treated With Radioactive Iodine Therapy.

J Clin Endocrinol Metab. 2023-11-17

[3]
The impact of iodinated contrast agent administered during preoperative computed tomography scan on body iodine pool in patients with differentiated thyroid cancer preparing for radioactive iodine treatment.

Thyroid. 2014-5

[4]
Combination of Stimulated Thyroglobulin and Antithyroglobulin Antibody Predicts the Efficacy and Prognosis of I Therapy in Patients With Differentiated Thyroid Cancer Following Total Thyroidectomy: A Retrospective Study.

Front Endocrinol (Lausanne). 2022

[5]
Radiotheragnostics Paradigm for Radioactive Iodine (Iodide) Management of Differentiated Thyroid Cancer.

Curr Pharm Des. 2020

[6]
Factors Influencing the Success of the First Radioiodine Therapy for Differentiated Thyroid Carcinoma.

J Med Assoc Thai. 2017-2

[7]
Effect of Waiting Time for Radioactive Iodine Therapy on Outcome in N1 Stage Papillary Thyroid Cancer.

J Clin Endocrinol Metab. 2023-10-18

[8]
Prognostic factors in children and adolescents with differentiated thyroid carcinoma treated with total thyroidectomy and RAI: a real-life multicentric study.

Eur J Nucl Med Mol Imaging. 2022-3

[9]
Survival benefit of postoperative radioiodine therapy among patients with intermediate-risk differentiated thyroid carcinoma.

Endocrine. 2024-11

[10]
Early preablation rhTSH-stimulated thyroglobulin predicts outcome of differentiated thyroid cancer (DTC) patients.

Eur J Nucl Med Mol Imaging. 2021-7

引用本文的文献

[1]
Dynamic Changes in Lymphocyte Subsets and Inflammation-Immune-Related Proteins in Patients with Thyroid Papillary Carcinoma before and after Radioactive Iodine Therapy.

J Proteome Res. 2025-6-6

[2]
Retinal Structure and Microcirculation Alterations in Patients With Papillary Thyroid Carcinoma: An Optical Coherence Tomography and Angiography Study.

Invest Ophthalmol Vis Sci. 2025-4-1

本文引用的文献

[1]
Positive Attributes of Anti-TERT CD4 T-Helper Type 1 Immune Responses in Melanoma.

J Invest Dermatol. 2022-2

[2]
CD4+ T cell and M2 macrophage infiltration predict dedifferentiated liposarcoma patient outcomes.

J Immunother Cancer. 2021-8

[3]
The emerging role of transcription factor FOXP3 in thyroid cancer.

Rev Endocr Metab Disord. 2022-6

[4]
Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity.

J Clin Invest. 2021-10-1

[5]
Recent advances in the role of Th17/Treg cells in tumor immunity and tumor therapy.

Immunol Res. 2021-10

[6]
Understanding and Targeting Human Cancer Regulatory T Cells to Improve Therapy.

Adv Exp Med Biol. 2021

[7]
The Many Faces of CD4 T Cells: Immunological and Structural Characteristics.

Int J Mol Sci. 2020-12-23

[8]
The clinical value of the changes of peripheral lymphocyte subsets absolute counts in patients with non-small cell lung cancer.

Transl Oncol. 2020-12

[9]
An IL6-Adenosine Positive Feedback Loop between CD73 γδTregs and CAFs Promotes Tumor Progression in Human Breast Cancer.

Cancer Immunol Res. 2020-10

[10]
Obesity as a risk factor for thyroid cancer.

Curr Opin Endocrinol Diabetes Obes. 2020-10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索